LPCN - Lipocine Inc Profit before interest, taxes and amortization

Brandmark of Lipocine (LPCN)

The automation of laboratory tests is accelerating the drug pipeline for Lipocine Inc. (LPCN), as illustrated by the actual operating profit on the GURU.Markets terminal line chart, where the 0.00 metric reflects current dynamics. The financial foundation relies on licensing payments for the Lip'or-Al platform, while investor confidence is bolstered by experienced management successfully advancing endocrine treatments into final-stage trials.

Lipocine Corp - LPCN Operating profit EBITDA (period 11/23/2025 - 11/12/2026)

Summary analytical data breakdowns for Lipocine (LPCN)

- current quotes and average value forecast:
Stock Quotes Lipocine Corporation|LPCN - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Lipocine|LPCN - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share Lipocine|LPCN - Book Capitalization|Market Capitalization to Book Value Ratio lipocine.com|LPCN - Company Total Assets
- company total debt and liquidity indicators:
Debt to Equity Lipocine Inc.|LPCN - Long-Term Debt to Equity|Current Liabilities to Capital Lipocine Inc|LPCN - Company Debts|Debt to Book Capitalization Ratio Lipocine|LPCN - Company Long-Term Debts|Short-Term Debt Volume Lipocine|Interim Coverage Ratio lipocine.com
- financial results and valuation multiples details:
LPCN - Company Net Income|Future Profit Lipocine Inc.|LPCN - Price to Earnings Ratio|Future Price to Earnings lipocine.com|LPCN - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Lipocine|LPCN - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Lipocine|LPCN - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months lipocine.com|LPCN - Earnings growth in current year|Expected earnings per share growth for next year Lipocine Inc.
Analysis of all company metrics:Lipocine Corporation (LPCN)
Manufactured products of Lipocine Inc.

Absolute operating profit measures the actual cash flow from core operations, stripped of the impact of depreciation and taxes, which allows for an assessment of the issuer's internal solvency. By analyzing the current EBITDA, an investor can see the financial foundation of Lipocine Inc. (LPCN), where the stability of this metric confirms the company's ability to develop delivery drugs through targeted licensing without the need for mergers.

Who Lipocine Inc. competes with

ASND - Operating profit before deduction of amortization|Madrigal Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization corcept.com|RYTM (Rhythm Pharmaceuticals, Inc.) - Operating profit before deduction of amortization|AKRO: Company profit before taxes, interest and amortization|MTSR (Metsera Corp) - Operating profit EBITDA|Operating profit EBITDA MoonLake Corp|Operating profit EBITDA CRNX|Profit before payment of interest, taxes and amortization NAMS (newamsterdampharma.com)|Profit before payment of interest, taxes and amortization Soleno Therapeutics, Inc. SLNO|Amicus Therapeutics Inc (FOLD) - Profit before interest, taxes and amortization|ETNB - Profit before payment of interest, taxes and amortization|AGIO: Profit before payment of interest, taxes and amortization|GPCR: Operating profit EBITDA|MDXG - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Rezolute|Lexicon Pharmaceuticals Inc (LXRX) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization MBX Bio (MBX)|Operating profit before deduction of amortization Altimmune Pharma ALT|Profit before payment of interest, taxes and amortization Aardvark Therapeutics Inc AARD|sagimet.com - Profit before payment of interest, taxes and amortization|BioAge - Operating profit EBITDA|Operating income before deduction of amortization Biomea Fusion Inc BMEA|quincetx.com (QNCX) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization GUTS (Fractyl Health, Inc)|Profit before payment of interest, taxes and amortization vTv Therapeutics, Inc.|Profit before interest, taxes and amortization Agape ATP Corp. ATPC|Operating profit EBITDA PLUR|Operating profit before deduction of amortization synlogictx.com SYBX|Operating profit EBITDA MTNB (Matinas BioPharma Holdings)|Operating income before deduction of amortization sprucebiosciences.com (SPRB)|GLTO - Profit before payment of interest, taxes and amortization|CTCX (carmellrx.com) - Operating profit before amortization|LUMO: Operating profit EBITDA|Profit before interest, taxes and amortization Organovo Holdings (ONVO)|Operating profit before deduction of amortization RDUS